[1] Mazmanian SK, Liu CH, Tzianabos AO, et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system[J]. Cell, 2005, 122:107-118.
[2] Tan TG, Sefik E, Geva-Zatorsky N, et al. Identifying species of symbiont bacteria from the human gut that, alone, can induce intestinal Th17 cells in mice[J]. ProcNatl Acad Sci U S A, 2016, 113: E8141-E8150.
[3] Cheng H, Guan X, Chen D, et al. The Th17/Treg cell balance: a gut microbiota-modulated story[J]. Microorganisms, 2019,7:583. doi: 10.3390/microorganisms7120583.
[4] Guzik TJ, Hoch NE, Brown KA, et al. Role of the T cell in the genesis of angiotensin Ⅱ induced hypertension and vascular dysfunction[J]. J Exp Med, 2007, 204:2449-2460.
[5] Saleh MA, Norlander AE, Madhur MS. Inhibition of interleukin 17-A but not interleukin-17F signaling lowers blood pressure and reduces end-organ inflammation in angiotensin Ⅱ-induced hypertension[J]. JACC Basic Transl Sci, 2016, 1:606-616.
[6] Du YN, Tang XF, Xu L, et al. SGK1-FoxO1 signaling pathway mediates Th17/Treg imbalance and target organ inflammation in angiotensin Ⅱ-induced hypertension[J]. Front Physiol, 2018, 9:1581. doi: 10.3389/fphys.2018.01581.
[7] Gilbert JA, Blaser MJ, Caporaso JG, et al. Current understanding of the human microbiome[J]. Nat Med, 2018, 24:392-400.
[8] Adnan S, Nelson JW, Ajami NJ, et al. Alterations in the gut microbiota can elicit hypertension in rats[J]. Physiol Genomics, 2017, 49:96-104.
[9] Marques FZ, Nelson E, Chu PY, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice[J]. Circulation, 2017, 135:964-977.
[10] Durgan DJ, Ganesh BP, Cope JL, et al. Role of the gut microbiome in obstructive sleep apnea-induced hyperten-sion[J]. Hypertension, 2016, 67:469-474.
[11] Li J, Zhao F, Wang Y, et al. Gut microbiota dysbiosis contributes to the development of hypertension[J]. Microbiome, 2017, 5:14. doi: 10.1186/s40168-016-0222-x.
[12] Karbach SH, Schönfelder T, Brandño I, et al. Gut microbiota promote angiotensin Ⅱ-induced arterial hypertension and vascular dysfunction[J]. J Am Heart Assoc, 2016, 5: e003698. doi: 10.1161/JAHA.116.003698.
[13] Yan Q, Gu Y, Li X, et al. Alterations of the gut microbiome in hypertension[J]. Front Cell Infect Microbiol, 2017, 7:381. doi: 10.3389/fcimb.2017.00381.
[14] Chen L, He FJ, Dong Y, et al. Modest sodium reduction increases circulating short-chain fatty acids in untreated hypertensives: a randomized, double-blind, placebo-controlled trial[J]. Hypertension, 2020, 76:73-79.
[15] Bartolomaeus H, Balogh A, Yakoub M, et al. Short-chain fatty acid propionate protects from hypertensive cardiovascular damage[J]. Circulation, 2019, 139:1407-1421.
[16] Morris G, Berk M, Carvalho A, et al. The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease[J]. Mol Neurobiol, 2017, 54:4432-4451.
[17] Ufnal M, Jazwiec R, Dadlez M, et al. Trimethylamine-N-oxide: a carnitine-derived metabolite that prolongs the hypertensive effect of angiotensin Ⅱ in rats[J].Can J Cardiol, 2014,30:1700-1705.
[18] Liu J, Li T, Wu H, et al. Lactobacillus rhamnosus GG strain mitigated the development of obstructive sleep apnea-induced hypertension in a high salt diet via regulat-ing TMAO level and CD4+ T cell induced-type I inflammation[J]. Biomed Pharmacother, 2019, 112:108580.doi:org/10.1016/j.biopha.2019.01.041.
[19] Bu J, Wang Z. Cross-talk between gut microbiota and heart via the routes of metabolite and immunity[J]. Gastroenterol Res Pract, 2018, 2018:6458094. doi: 10.1155/2018/6458094.
[20] Wilck N, Matus MG, Kearney SM, et al. Salt-responsive gut commensal modulates TH17 axis and disease[J]. Nature, 2017, 551:585-589.
[21] Miranda PM, De Palma G, Serkis V, et al. High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production[J]. Microbiome, 2018, 6:57. doi: 10.1186/s40168-018-0433-4.
[22] Bier A, Braun T, Khasbab R, et al. A high salt diet modulates the gut microbiota and short chain fatty acids production in a salt-sensitive hypertension rat model[J]. Nutrients, 2018, 10:1154. doi: 10.3390/nu10091154.
[23] Yan X, Jin J, Su X, et al. Intestinal flora modulates blood pressure by regulating the synthesis of intestinal-derived corticosterone in high salt-induced hypertension[J]. Circ Res, 2020, 126:839-853.
[24] Liu B, Zhang Y, Wang R, et al. Western diet feeding influences gut microbiota profiles in apoE knockout mice[J]. Lipids Health Dis, 2018, 17:159. doi: 10.1186/s12944-018-0811-8.
[25] Christ A, Günther P, Lauterbach MAR, et al. Western diet triggers NLRP3-dependent innate immune reprogramming[J]. Cell, 2018, 172:162-175.
[26] Tran HQ, Bretin A, Adeshirlarijaney A, et al. “Western Diet”-induced adipose inflammation requires a complex gut microbiota[J]. Cell Mol Gastroenterol Hepatol, 2020, 9:313-333.
[27] Jennings A, Berendsen AM, de Groot L, et al. Mediterranean-style diet improves systolic blood pressure and arterial stiffness in older adults[J]. Hypertension, 2019, 73:578-586.
[28] De Filippis F, Pellegrini N, Vannini L, et al. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome[J]. Gut, 2016, 65:1812-1821.
[29] Ghosh TS, Rampelli S, Jeffery IB, et al. Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries[J]. Gut, 2020, 69:1218-1228. |
